Cargando…
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
PURPOSE: More accurate prediction of patient outcome based on molecular subtype is required to identify patients who will benefit from specific treatments. METHODS: We selected novel 16 candidate prognostic genes, including 10 proliferation-related genes (p-genes) and 6 immune response-related genes...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487710/ https://www.ncbi.nlm.nih.gov/pubmed/28409241 http://dx.doi.org/10.1007/s10549-017-4234-4 |